Finance ForgeBETA
Crear cuenta gratis
1)Empresas2)Rankings3)Iniciar sesión
Finance Forge Terminal v1.49.5
PrivacidadTérminosCookiesAviso Legal
● Connected
SYK US Equity
STRYKER CORP
277.33USD▲ 0.13%
Healthcare
Medical Devices
96)Comparar97)Tesis →
Market Cap
$106.4B
Shares Outstanding
384M
EV/EBITDA
18.3×
— Annual —FY2025
Revenue
$25.1B
Gross Margin
64.0%
Operating Margin
19.5%
Net Margin
12.9%
FCF Margin
17.1%
ROE
14.5%
ROCE
12.2%
Net Debt/EBITDA
1.8×
Current Ratio
1.89
D/E Ratio
0.66
Dividend Yield
1.2%
FCF / Share
11.17
Book Value / Share
58.45
SYK US Equity
277.33USD▲ 0.13%
Tesis →

STRYKER CORP (SYK): análisis fundamental y valoración

STRYKER CORP cotiza a 277.33 USD y tiene una capitalización bursátil de $106.4B. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud

Price History
Loading...
Perfil
BolsaNYSEPaísUnited StatesEmpleados56,000Beta0.77Web↗ www.stryker.com

Stryker Corporation operates as a medical technology company in the United States and internationally. It operates through two segments, MedSurg and Neurotechnology, and Orthopaedics. The MedSurg and Neurotechnology segment offers surgical equipment, patient and caregiver safety technologies, navigation systems, endosc…

Múltiplos de Valoración
P/E (Annual)
32.8×
P/E (TTM)
—
P/FCF (Annual)
24.8×
P/FCF (TTM)
—
EV/EBITDA
18.3×
EV/Revenue
4.7×
P/Sales
4.2×
P/Book
4.7×
Rentabilidad (Último Anual)
Gross Margin
64.0%
Operating Margin
19.5%
Net Margin
12.9%
FCF Margin
17.1%
ROE
14.5%
ROCE
12.2%
ROA
6.8%
Effective Tax Rate
28.1%
Métricas TTM
Revenue TTM
—
Gross Profit TTM
—
Operating Income TTM
—
Net Income TTM
—
FCF TTM
—
EPS TTM
—
Quarters Used
—
TTM Period
—
Solidez del Balance
Net Debt
$11.8B
Net Debt / EBITDA
1.8×
Debt / Equity
0.66
Current Ratio
1.89
Interest Coverage
8.4×
Working Capital
$7.0B
Book Value / Share
58.45
Net Debt / Share
30.89
Crecimiento (YoY)
Revenue YoY
+11.2%
Net Income YoY
+8.4%
FCF YoY
+22.8%
EPS Diluted YoY
+8.3%
Retorno al Accionista
Dividend Yield
1.2%
Payout Ratio
39.6%
FCF / Share
11.17
CapEx % Revenue
3.0%
Rev / Employee
448,500
Próximos Eventos
Ex-Dividendo
2026-09-30
Pago Dividendo
2026-10-30
Historial EPS
Periodo2026-102026-072026-042026-01
Real—$3.69$2.60$4.47
Estimado$3.56$3.49$2.98$4.40
Sorpresa—+5.7%-12.8%+1.6%
Empresas similares
Smart Money
vs Sector: Healthcare (1130 empresas)
MétricaSYKMediana SectorΔ
Gross Margin64.0%57.0%+6.9%
Operating Margin19.5%-38.6%+58.1%
Net Margin12.9%-33.6%+46.5%
FCF Margin17.1%-13.9%+30.9%
ROE14.5%-40.4%+54.9%
ROA6.8%-32.0%+38.8%
Current Ratio1.892.84-0.95
Debt / Equity0.660.28+0.38
Scoring Fundamental
Piotroski F-Score
4/ 9Débil
✓F1ROA positivo (rentabilidad activos)
✓F2Flujo caja operativo positivo
✗F3ROA mejora vs año anterior
✓F4Calidad de beneficios (OCF > ROA)
✗F5Apalancamiento baja
✗F6Liquidez mejora (current ratio)
✗F7Sin dilución accionarial
✓F8Margen bruto mejora
✗F9Rotación activos mejora
Altman Z-ScoreZona Segura
4.15
x1_working_capital0.145
x2_retained_earnings0.428
x3_ebit0.102
x4_market_equity4.184
x5_sales0.525
>2.99 segura · 1.81–2.99 gris · <1.81 riesgo
Capital Allocation
8/ 8Sólida
✓FCF+Free cash flow positivo
✓FCFmMargen FCF > 10%
✓DilucSin dilución significativa (< 2%/año en 3 años)
✓Rev↑Revenue CAGR 3 años > 5%
✓ROCERetorno sobre capital empleado > 10%
✓DeudaDeuda neta/EBITDA < 3× (o posición de caja neta)
✓Mg↑Margen operativo ≥ hace 2-3 años (tolerancia -2pp)
✓Inv.R&D + Capex > 3% de revenue (reinversión en el negocio)
Histórico Piotroski F-Score
Histórico de Múltiplos